RxDoctor Payments Data

Tobechukwu Clouden, MD

Psychiatry · Newark, NJNPI 1669603387

Payments from drug & device makers

$3,676in general payments, 2019–2025

Across 242 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$864
  • Teva Pharmaceuticals USA, Inc.$620
  • AbbVie$509
  • Alkermes, Inc.$424
  • Otsuka America Pharmaceutical, Inc.$423
  • Neurocrine Biosciences, Inc.$259
  • plus $577 from 6 others

What the payments were for

  • Food & beverage$3,46194%
  • Education$2146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,676 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$42,903
Medicare patients
125
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole39$106,181
Invega SustennaPaliperidone Palmitate31$84,045
Lurasidone Hcl38$23,742
VraylarCariprazine Hcl11$18,182
RexultiBrexpiprazole11$14,372
Clozapine127$14,062
Aripiprazole70$6,050
TrintellixVortioxetine Hydrobromide11$5,729
Bupropion XlBupropion Hcl91$5,523
Zyprexa ZydisOlanzapine11$5,433
Divalproex Sodium ErDivalproex Sodium41$3,213
Quetiapine Fumarate108$2,955
Duloxetine Hcl144$2,577
Olanzapine84$2,309
Hydroxyzine Hcl97$2,272

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$423$120,55450 claims
Johnson & JohnsonInvega Sustenna$864$84,04531 claims
AbbVieVraylar$509$18,18211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →